
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Accepting some risks and investing in time and staffing are needed to build out service models.
David Nau, PhD, RPHA, of Nova Southeastern University, said that "it's not an easy transition, to move from a largley dispsensing-centered model to patient care in pharmacy.






